Misuse and abuse of pregabalin and gabapentin: cause for concern?

F Schifano - CNS drugs, 2014 - Springer
Gabapentinoids (eg pregabalin and gabapentin) are widely used in neurology, psychiatry
and primary healthcare but are increasingly being reported as possessing a potential for …

New directions in the treatment of opioid withdrawal

AB Srivastava, JJ Mariani, FR Levin - The Lancet, 2020 - thelancet.com
The treatment of opioid withdrawal is an important area of clinical concern when treating
patients with chronic, non-cancer pain, patients with active opioid use disorder, and patients …

Effect of perioperative gabapentin on postoperative pain resolution and opioid cessation in a mixed surgical cohort: a randomized clinical trial

J Hah, SC Mackey, P Schmidt, R McCue… - JAMA …, 2018 - jamanetwork.com
Importance Guidelines recommend using gabapentin to decrease postoperative pain and
opioid use, but significant variation exists in clinical practice. Objective To determine the …

Pharmacologic treatment of opioid use disorder: a review of pharmacotherapy, adjuncts, and toxicity

MS Toce, PR Chai, MM Burns, EW Boyer - Journal of Medical Toxicology, 2018 - Springer
Opioid use disorder continues to be a significant source of morbidity and mortality in the
USA and the world. Pharmacologic treatment with methadone and buprenorphine has been …

Gabapentin for the treatment of alcohol use disorder

BJ Mason, S Quello, F Shadan - Expert opinion on investigational …, 2018 - Taylor & Francis
Introduction: Alcohol misuse is the fifth leading risk factor for premature death and disability
worldwide. Fewer than 10% of afflicted Americans receive pharmacological treatment for …

Use of gabapentin in the treatment of substance use and psychiatric disorders: a systematic review

S Ahmed, R Bachu, P Kotapati, M Adnan… - Frontiers in …, 2019 - frontiersin.org
Objective: Gabapentin (GBP) is an anticonvulsant medication that is also used to treat
restless legs syndrome (RLS) and posttherapeutic neuralgia. GBP is commonly prescribed …

[HTML][HTML] Gabapentin therapy in psychiatric disorders: a systematic review

RK Berlin, PM Butler, MD Perloff - The primary care companion for …, 2015 - psychiatrist.com
Objective: Gabapentin is commonly used off-label in the treatment of psychiatric disorders
with success, failure, and controversy. A systematic review of the literature was performed to …

[HTML][HTML] Consuming illicit opioids during a drug overdose epidemic: Illicit fentanyls, drug discernment, and the radical transformation of the illicit opioid market

SED Clarke, AH Kral, JE Zibbell - International Journal of Drug Policy, 2022 - Elsevier
Abstract Background North America continues to face an opioid overdose epidemic, driven
by persistent increases in illicit fentanyls and fluctuations in potency leading to uncertainty …

Understanding the rise in overdose deaths involving opioids and non-opioid prescription drugs in the United States

D Powell, ED Peet, RL Pacula - International Journal of Drug Policy, 2023 - Elsevier
Background Previous studies demonstrate that the reformulation of OxyContin in the US in
2010 induced substitution to illicit opioids, causing illicit opioid markets to grow …

Pharmacological strategies for detoxification

AM Diaper, FD Law, JK Melichar - British Journal of Clinical …, 2014 - Wiley Online Library
Detoxification refers to the safe discontinuation from a substance of dependence and is
distinct from relapse prevention. Detoxification usually takes between a few days and a few …